AZZAD ASSET MANAGEMENT INC /ADV

Position in INCY — Incyte Corp

CIK 1121914 FALLS CHURCH, VA

Position in INCY

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$1,027,835

-$440,813 QoQ

Shares Held

9,067

-41.9% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

#406

of 849 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

AZZAD ASSET MANAGEMENT INC /ADV holds $5,807,017 across 7 Biotechnology names. INCY ranks #2 (17.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	4,630	$1,393,768
2	INCY	Incyte Corp This page	9,067	$1,027,835
3	TECH	BIO-TECHNE Corp	14,008	$989,665
4	HALO	Halozyme Therapeutics, Inc.	12,424	$972,426
5	REGN	Regeneron Pharmaceuticals, Inc.	984	$613,563
6	EXEL	Exelixis, Inc.	7,911	$430,437
7	IONS	Ionis Pharmaceuticals Inc	4,784	$379,323

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,027,835	9,067	-41.9%	Shares	Sole	2026-07-29
2026-03-31	$1,468,648	15,604	-0.9%	Shares	Sole	2026-04-30
2025-12-31	$1,554,936	15,743	-2.8%	Shares	Sole	2026-01-21
2025-09-30	$1,373,582	16,196	+120.3%	Shares	Sole	2025-11-05
2022-09-30	$490,003	7,353	0.0%	Shares	Sole	2024-04-01
2022-06-30	$558,607	7,353	-53.0%	Shares	Sole	2024-04-01
2021-06-30	$1,315,624	15,638	+2.7%	Shares	Sole	2024-04-01
2021-03-31	$1,237,742	15,230	+325.1%	Shares	Sole	2024-04-01
2020-12-31	$311,649	3,583	-50.0%	Shares	Sole	2024-04-01
2020-09-30	$642,897	7,164	-0.0%	Shares	Sole	2024-04-01
2020-06-30	$745,049	7,166	-0.0%	Shares	Sole	2024-04-01
2020-03-31	$524,985	7,169	—	Shares	Sole	2024-04-01
No filing history on record for this holder in this stock.